Evaluation of florbetapir (18F) PET in subjects participating in the IRCCSFBF protocol

Trial Profile

Evaluation of florbetapir (18F) PET in subjects participating in the IRCCSFBF protocol

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2016

At a glance

  • Drugs Florbetapir F 18 (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Diagnostic use; Registrational
  • Acronyms India-FBP
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 31 Oct 2016 Results assessing incremental diagnostic value of florbetapir F 18 imaging ublished in the JAMA Neurology.
    • 07 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top